124 related articles for article (PubMed ID: 29262634)
1. Glucose-derived AGEs enhance human gastric cancer metastasis through RAGE/ERK/Sp1/MMP2 cascade.
Deng R; Mo F; Chang B; Zhang Q; Ran H; Yang S; Zhu Z; Hu L; Su Q
Oncotarget; 2017 Nov; 8(61):104216-104226. PubMed ID: 29262634
[TBL] [Abstract][Full Text] [Related]
2. Glucose-derived AGEs promote migration and invasion of colorectal cancer by up-regulating Sp1 expression.
Deng R; Wu H; Ran H; Kong X; Hu L; Wang X; Su Q
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt A):1065-1074. PubMed ID: 28237576
[TBL] [Abstract][Full Text] [Related]
3. Role of receptor for advanced glycation end-products and signalling events in advanced glycation end-product-induced monocyte chemoattractant protein-1 expression in differentiated mouse podocytes.
Gu L; Hagiwara S; Fan Q; Tanimoto M; Kobata M; Yamashita M; Nishitani T; Gohda T; Ni Z; Qian J; Horikoshi S; Tomino Y
Nephrol Dial Transplant; 2006 Feb; 21(2):299-313. PubMed ID: 16263740
[TBL] [Abstract][Full Text] [Related]
4. Advanced glycation endproducts increase proliferation, migration and invasion of the breast cancer cell line MDA-MB-231.
Sharaf H; Matou-Nasri S; Wang Q; Rabhan Z; Al-Eidi H; Al Abdulrahman A; Ahmed N
Biochim Biophys Acta; 2015 Mar; 1852(3):429-41. PubMed ID: 25514746
[TBL] [Abstract][Full Text] [Related]
5. Expression of receptors for advanced glycation end-products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer.
Kuniyasu H; Oue N; Wakikawa A; Shigeishi H; Matsutani N; Kuraoka K; Ito R; Yokozaki H; Yasui W
J Pathol; 2002 Feb; 196(2):163-70. PubMed ID: 11793367
[TBL] [Abstract][Full Text] [Related]
6. Cell migration is regulated by AGE-RAGE interaction in human oral cancer cells in vitro.
Ko SY; Ko HA; Shieh TM; Chang WC; Chen HI; Chang SS; Lin IH
PLoS One; 2014; 9(10):e110542. PubMed ID: 25330185
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of RAGE expression inhibits colorectal cancer cell invasion and suppresses angiogenesis in vitro and in vivo.
Liang H; Zhong Y; Zhou S; Peng L
Cancer Lett; 2011 Dec; 313(1):91-8. PubMed ID: 21945853
[TBL] [Abstract][Full Text] [Related]
8. Advanced glycation end products impair the functions of saphenous vein but not thoracic artery smooth muscle cells through RAGE/MAPK signalling pathway in diabetes.
Sun Y; Kang L; Li J; Liu H; Wang Y; Wang C; Zou Y
J Cell Mol Med; 2016 Oct; 20(10):1945-55. PubMed ID: 27297874
[TBL] [Abstract][Full Text] [Related]
9. Loss of phosphatase and tensin homolog enhances cell invasion and migration through AKT/Sp-1 transcription factor/matrix metalloproteinase 2 activation in hepatocellular carcinoma and has clinicopathologic significance.
Sze KM; Wong KL; Chu GK; Lee JM; Yau TO; Ng IO
Hepatology; 2011 May; 53(5):1558-69. PubMed ID: 21520171
[TBL] [Abstract][Full Text] [Related]
10. LPPR4 promotes peritoneal metastasis via Sp1/integrin α/FAK signaling in gastric cancer.
Zang D; Zhang C; Li C; Fan Y; Li Z; Hou K; Che X; Liu Y; Qu X
Am J Cancer Res; 2020; 10(3):1026-1044. PubMed ID: 32266108
[TBL] [Abstract][Full Text] [Related]
11. Advanced glycation end products induce calcification of vascular smooth muscle cells through RAGE/p38 MAPK.
Tanikawa T; Okada Y; Tanikawa R; Tanaka Y
J Vasc Res; 2009; 46(6):572-80. PubMed ID: 19571577
[TBL] [Abstract][Full Text] [Related]
12. Advanced glycation end-products activate extracellular signal-regulated kinase via the oxidative stress-EGF receptor pathway in renal fibroblasts.
Chen SC; Guh JY; Hwang CC; Chiou SJ; Lin TD; Ko YM; Huang JS; Yang YL; Chuang LY
J Cell Biochem; 2010 Jan; 109(1):38-48. PubMed ID: 19885844
[TBL] [Abstract][Full Text] [Related]
13. Atorvastatin prevents advanced glycation end products (AGEs)-induced cardiac fibrosis via activating peroxisome proliferator-activated receptor gamma (PPAR-γ).
Chen M; Li H; Wang G; Shen X; Zhao S; Su W
Metabolism; 2016 Apr; 65(4):441-53. PubMed ID: 26975536
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of immunogenic cell death biomarker rage and early growth response 1 in human primary gastric adenocarcinoma.
Xu XC; Gao H; Zhang WB; Abuduhadeer X; Wang YH
Int J Immunopathol Pharmacol; 2013; 26(2):485-93. PubMed ID: 23755764
[TBL] [Abstract][Full Text] [Related]
15. The protective effect of Smilax glabra extract on advanced glycation end products-induced endothelial dysfunction in HUVECs via RAGE-ERK1/2-NF-κB pathway.
Sang HQ; Gu JF; Yuan JR; Zhang MH; Jia XB; Feng L
J Ethnopharmacol; 2014 Aug; 155(1):785-95. PubMed ID: 24953033
[TBL] [Abstract][Full Text] [Related]
16. Advanced glycation end-products induced VEGF production and inflammatory responses in human synoviocytes via RAGE-NF-κB pathway activation.
Chen YJ; Chan DC; Chiang CK; Wang CC; Yang TH; Lan KC; Chao SC; Tsai KS; Yang RS; Liu SH
J Orthop Res; 2016 May; 34(5):791-800. PubMed ID: 26497299
[TBL] [Abstract][Full Text] [Related]
17. The anti-inflammation effect of Moutan Cortex on advanced glycation end products-induced rat mesangial cells dysfunction and High-glucose-fat diet and streptozotocin-induced diabetic nephropathy rats.
Zhang MH; Feng L; Zhu MM; Gu JF; Jiang J; Cheng XD; Ding SM; Wu C; Jia XB
J Ethnopharmacol; 2014; 151(1):591-600. PubMed ID: 24269777
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of ethyl pyruvate administration on human gastric cancer growth via regulation of the HMGB1-RAGE and Akt pathways in vitro and in vivo.
Zhang J; Zhu JS; Zhou Z; Chen WX; Chen NW
Oncol Rep; 2012 May; 27(5):1511-9. PubMed ID: 22246223
[TBL] [Abstract][Full Text] [Related]
19. Metformin inhibits advanced glycation end products (AGEs)-induced growth and VEGF expression in MCF-7 breast cancer cells by suppressing AGEs receptor expression via AMP-activated protein kinase.
Ishibashi Y; Matsui T; Takeuchi M; Yamagishi S
Horm Metab Res; 2013 May; 45(5):387-90. PubMed ID: 23225247
[TBL] [Abstract][Full Text] [Related]
20. Metformin inhibits advanced glycation end products (AGEs)-induced renal tubular cell injury by suppressing reactive oxygen species generation via reducing receptor for AGEs (RAGE) expression.
Ishibashi Y; Matsui T; Takeuchi M; Yamagishi S
Horm Metab Res; 2012 Nov; 44(12):891-5. PubMed ID: 22864903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
